Lorbrexen 100 MG (Lorlatinib) – 30 Tablets

$380.00

Lorbrexen 100 mg (Lorlatinib) is a potent, brain-penetrant, third-generation inhibitor of ALK and ROS1 tyrosine kinases with broad coverage of ALK mutations. In a phase 1 study, activity was seen in patients with ALK-positive non-small-cell lung cancer, most of whom had CNS metastases and progression after ALK-directed therapy.

whatsapp_qr
Whatsapp +8801922101029